Skip to content

in vivo data availabletarget validated in vivo


Technology Listing:

Novel Prostaglandin Receptor-Mediated Activator as Treatment of Airway CFTR Mutations - 20-04

CBX7 and MEK2: New Targets for Steroid Resistant Asthma - 18-05

Novel Inhibitors of DksA Effective Against Gram-Negative Bacteria - 18-03

Selenocyanate as Antimicrobial Against Lung Infections - 17-09

Targeting CYP11A1 in the Steroidogenic Pathway For Treating Allergic Diseases - 11-17

B Cells Desensitization with an Anti-CD79 Antibody: Therapeutic Approach for Autoimmune Diseases - 11-15 in vivo data available

PTPN13: A Novel Target for the Treatment of Pulmonary Fibrosis - 11-09 in vivo data available

PIM 1 Kinase Inhibition for the Treatment of Allergic Diseases - 11-06 in vivo data available

Novel TLR Inhibitors Prevent Respiratory Syncytial Virus Infection In Vivo - 07-07 in vivo data available

MAGP-2: An extracellular factor shown to have pro-angiogenic properties - 06-05 in vivo data available

Sulfasalazine as a Treatment for Sarcoidosis - Results of a Clinical Pilot Study - 04-09

Method to prevent biofilm formation in various clinical settings (contact lenses, wounds, cystic fibrosis, etc.) - 04-08 in vivo data available

Modulating the transport of thiol-containing molecules for the treatment of lung disease and cancer - 02-16 in vivo data available

Liposomal clodronate as a therapy for autoimmune hemolytic anemia - 02-07 in vivo data available

TALL-1 and its Receptor BCMA: Molecular Targets for the Development of Therapies Against Autoimmune Diseases -  02-01

Aerosolized Anti-Human CD3 Antibodies Decrease Airway Hyperresponsiveness in Non- Human Primates - 01-01 in vivo data available



View list of available Diagnostics.


Research Tools

View list of available Antibodies or Animal models.


Biomedical Devices

View list of available biomedical devices.

For more information, contact Emmanuel Hilaire at